Replimune Group, Inc. (REPL)
4.70
-0.31
(-6.19%)
USD |
NASDAQ |
May 19, 16:00
4.73
+0.03
(+0.64%)
After-Hours: 20:00
Replimune Group Cash from Operations (Annual) : -192.25M for March 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| REGENXBIO, Inc. | -123.96M |
| Catalyst Pharmaceuticals, Inc. | 208.67M |
| Spyre Therapeutics, Inc. | -169.41M |
| Bristol Myers Squibb Co. | 14.16B |
| ANI Pharmaceuticals, Inc. | 185.22M |